Evidence map›Paper›PMID 41063134›Full record

Observational studyBMC musculoskeletal disorders2025

Limited effects of non-steroidal anti-inflammatory drugs (NSAIDs) on imaging outcomes in osteoarthritis: observational data from the osteoarthritis initiative (OAI).

Virginie Kreutzinger, Katharina Ziegeler, Johanna Luitjens, Gabby B Joseph, John Lynch, Nancy E Lane, Charles E McCulloch, Michael Nevitt, Thomas M Link

Abstract readObservational StudyMulticenter Study
In one paragraph

Observational study in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Pharmaceuticals (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Anti-Inflammatory Properties of Resveratrol.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Virginie KreutzingerDepartment of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, CA, USA. v.kreutzinger@googlemail.com.ORCID http://orcid.org/0009-0005-7378-1068
Katharina ZiegelerDepartment of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, CA, USA.
Johanna LuitjensDepartment of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, CA, USA.
Gabby B JosephDepartment of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, CA, USA.
John LynchDepartment of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, CA, USA.
Nancy E LaneDepartment of Medicine, Center for Musculoskeletal Health, University of California - Davis, Sacramento, CA, USA.
Charles E McCullochDepartment of Epidemiology and Biostatistics, University of California - San Francisco, San Francisco, CA, USA.
Michael NevittDepartment of Epidemiology and Biostatistics, University of California - San Francisco, San Francisco, CA, USA.
Thomas M LinkDepartment of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, CA, USA.

Funding

Skeletal Biology and Biomechanics (SBB) CoreP30AR075055 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Wenhan Chang · 2019 to 2026
$7.1M
Foundation for the National Institutes of Health R01-AG070647Foundation for the National Institutes of Health R01-AR078917NIAMS NIH HHS P30 AR075055
6 · The paper itself

Abstract

backgroundNon-steroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed for pain relief in osteoarthritis (OA), and their anti-inflammatory effects may play a role in shaping the disease course. The aim of this investigation was to examine the relationship between new use of prescription NSAIDs and changes in imaging biomarkers of synovitis in the knee, and to evaluate the association of NSAID use with structural cartilage damage over a period of four years.

methodsApplying a new user design to identify treatment effects in observational data, we selected participants from the Osteoarthritis Initiative (OAI) who were prescribed regular, oral NSAID medication between baseline and 48 months follow-up and who had available 3T MRIs of the right knee with whole-organ magnetic resonance imaging score (WORMS) readings as well as semi-quantitative assessments of synovitis for both timepoints. These individuals were frequency-matched with non-NSAID users matching for age, gender, body mass index (BMI), baseline Kellgren & Lawrence (KL) grade, Western Ontario and McMaster Universities Osteoarthritis (WOMAC) scores, and for the presence of an inflammatory imaging phenotype at baseline. Ordinal regression analyses and marginal estimated means were used to determine the effect of NSAID use on structural imaging outcomes, controlling for age, gender, BMI, and non-prescription NSAID use.

resultsIn this longitudinal analysis over 48 months, 142 individuals met prespecified criteria for new NSAID exposure, and 707 matched controls were identified. Regression analyses did not show a significant association between new NSAID use and changes in effusion-synovitis, Hoffa's synovitis, or synovial proliferation scores over 4 years. However, NSAID users showed a significantly slower progression of cartilage lesions as measured by WORMS grading; this effect was marginally more pronounced in participants with an inflammatory imaging phenotype (beta - 0.92; p = 0.043) than in the population overall (beta - 0.48; p = 0.020).

conclusionNew NSAID use was not associated with MRI-detected synovitis over 4 years but had a modest association with reduced structural cartilage damage progression. This effect was more pronounced in individuals with an inflammatory imaging phenotype.

Indexed as

Anti-Inflammatory Agents, Non-SteroidalKnee JointMagnetic Resonance ImagingOsteoarthritis, KneeSynovitisAgedDisease ProgressionFemaleFollow-Up StudiesHumansLongitudinal StudiesMaleMiddle AgedTreatment OutcomeAnti-Inflammatory Agents, Non-SteroidalImaging phenotypesKnee osteoarthritisMagnetic resonance imagingNSAID

Identifiers

PMID41063134
PMCPMC12505722

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.